Clinical Characteristics of Patients with Primary or Post-Polycythemia Vera/Post-Essential Thrombocytopenia Myelofibrosis and Deletion 13q
Deletion 13q [del(13q)] occurs rarely in patients with primary myelofibrosis (PMF) and as a single cytogenetic abnormality confers a favorable prognosis. Little is known about the prognostic impact of del(13q) in patients with post-polycythemia vera/post-essential thrombocytopenia myelofibrosis (PET/PPV-MF).
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Lucia Masarova, Kate Newberry, Jorge Cortes, Hagop Kantarjian, Srdan Verstovsek Source Type: research